AS601245 - ≥95%, high purity , CAS No.345987-15-7, Inhibitor of mitogen-activated protein kinase 10

Item Number
A275935
Grouped product items
SKUSizeAvailabilityPrice Qty
A275935-1mg
1mg
In stock
$28.90
A275935-5mg
5mg
In stock
$117.90
A275935-10mg
10mg
In stock
$206.90
A275935-25mg
25mg
In stock
$465.90
A275935-50mg
50mg
In stock
$800.90
A275935-100mg
100mg
In stock
$1,335.90

Potent, selective, ATP competitive JNK inhibitor. Cell-permeable.

Basic Description

SynonymsVNA98715 | HY-11010 | Q27163222 | 2-(4-dimethylaminophenyl)-1h-benzimidazole | 2-Benzothiazoleacetonitrile, alpha-(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)- | benzoic acid (4-oxo-cyclohexyl) ester | (2s)-1,3-Benzothiazol-2-Yl{2-[(2-Pyridin-3-Ylethyl
Specifications & PurityMoligand™, ≥95%
Biochemical and Physiological MechanismsPotent, selective, ATP competitive JNK inhibitor (IC 50 values are 150, 220 and 70 nM for hJNK1,2 and 3 respectively). Reduces cell adhesion and migration in cancer cells. anti-ischemic effects in vivo .
Storage TempStore at -20°C,Desiccated
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of mitogen-activated protein kinase 10
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.


product description:

A cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive inhibitor of c-Jun N-terminal kinase (JNK, IC50 = 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively) with a 10- to 100-fold greater selectivity over a panel of 25 other commonly studied kinases (IC50 typically in the range of 1-10 µM or no effect at 10 µM). Its in vivo efficacy has been demonstrated in gerbils, mice, and rats via oral, i.v., or i.p. administration. 


Biochemical mechanism:

Cell permeable: yes

Product competes with ATP.

Primary Target

hJNK 1, hJNK 2, hJNK 3

Reversible: yes

Target IC50: 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively

Associated Targets(Human)

MAPK10 Tchem Mitogen-activated protein kinase 10 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAPK8 Tchem c-Jun N-terminal kinase, JNK (688 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name 2-(1,3-benzothiazol-2-yl)-2-[2-(2-pyridin-3-ylethylamino)pyrimidin-4-yl]acetonitrile
INCHI InChI=1S/C20H16N6S/c21-12-15(19-25-17-5-1-2-6-18(17)27-19)16-8-11-24-20(26-16)23-10-7-14-4-3-9-22-13-14/h1-6,8-9,11,13,15H,7,10H2,(H,23,24,26)
InChi Key RCYPVQCPYKNSTG-UHFFFAOYSA-N
Canonical SMILES C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4
Isomeric SMILES C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4
PubChem CID 10109823
Molecular Weight 372.45

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot NumberCertificate TypeDateItem
B2318670Certificate of AnalysisDec 21, 2023 A275935
B2318673Certificate of AnalysisDec 21, 2023 A275935
B2318688Certificate of AnalysisDec 21, 2023 A275935
B2318823Certificate of AnalysisDec 21, 2023 A275935
B2318880Certificate of AnalysisDec 21, 2023 A275935
B2318885Certificate of AnalysisDec 21, 2023 A275935

Chemical and Physical Properties

SolubilitySoluble in DMSO to 25 mM

Related Documents

References

1. Gaillard P, Jeanclaude-Etter I, Ardissone V, Arkinstall S, Cambet Y, Camps M, Chabert C, Church D, Cirillo R, Gretener D et al..  (2005)  Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase..  J Med Chem,  48  (14): (4596-607).  [PMID:15999997]
2. Ivshina MP et al..  (2022)  CPEB1 regulates the inflammatory immune response, phagocytosis, and alternative polyadenylation in microglia..  Glia,  70  (10): (1850-1863).  [PMID:35635122]

Solution Calculators